CyNetSVM

CyNetSVM integrates gene expression data with protein-protein interaction (PPI) networks using network-constrained support vector machines (NetSVM) to identify network biomarkers and predict clinical outcomes in cancer research.


Key Features:

  • Integration with Cytoscape: Operates as a Cytoscape application to connect analyses with biological network visualization and attribute data.
  • Gene expression and PPI integration: Integrates gene expression profiles with protein-protein interaction (PPI) networks to enable network-based biomarker discovery.
  • Network-constrained Support Vector Machines (NetSVM): Implements NetSVM that constrains support vector machines by incorporating network topology to prioritize biologically coherent features.
  • Computational efficiency: Optimizes performance for analyses on large genomic datasets.
  • Network visualization capabilities: Visualizes identified subnetworks within biological networks to contextualize biomarkers in signaling pathways.

Scientific Applications:

  • Cancer outcome prediction: Identifies subnetworks predictive of clinical outcomes, including breast cancer recurrence, from gene expression and PPI data.
  • Network biomarker discovery: Pinpoints biomarkers enriched in signaling pathways relevant to cancer progression to inform prognosis and treatment response.

Methodology:

Integrates gene expression profiles with PPI data to construct a network-based model and applies the NetSVM algorithm, which constrains SVMs by network topology, to identify subnetworks predictive of clinical outcomes and genes central within those networks.

Topics

Details

Tool Type:
desktop application
Operating Systems:
Linux, Windows, Mac
Programming Languages:
Java
Added:
6/20/2018
Last Updated:
11/25/2024

Operations

Publications

Shi X, Banerjee S, Chen L, Hilakivi-Clarke L, Clarke R, Xuan J. CyNetSVM: A Cytoscape App for Cancer Biomarker Identification Using Network Constrained Support Vector Machines. PLOS ONE. 2017;12(1):e0170482. doi:10.1371/journal.pone.0170482. PMID:28122019. PMCID:PMC5266326.

PMID: 28122019
PMCID: PMC5266326
Funding: - National Cancer Institute: 149147, 149653, 164384, 184902

Documentation